In 2020, the total Canadian anesthesia device market size was valued at $36.6 million, including the video laryngoscope market valued at $4 million. The total market size is expected to increase at a compound annual growth rate (CAGR) of 2% to reach approximately $42 million in 2026. Throughout this medical market research, we analyzed 19
Industry Trends Oxygen therapy devices, sleep diagnostic devices and respiratory disposables, are expected to be the fastest-growing segments in the European anesthesia, respiratory and sleep management device market. As an alternative to the centralized delivery of concentrated oxygen, devices that allow patients to generate their own oxygen at home have played a significant role. This
Price erosion is apparent in all segments but has been more pronounced in the hospital OR setting. Competitive pressures are arising as competitors who typically played in low and mid-complexity markets have entered the high-complexity market, offering machines at lower prices than the existing products in the market. Overall, due to low unit growth and
The full report suite on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices includes anesthesia delivery units (ADU), anesthesia monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea (sleep therapy) devices and sleep diagnostic devices.
In 2021, the Europe anesthesia, respiratory and sleep therapy devices market size is estimated to reach €1.8 billion, with the Sleep Diagnostic Device market expected to experience the fastest growth. In spite of COVID19, the EU market size is projected to increase over the forecast period to exceed $1.8 billion in 2027. Currently, over 35%
This report analyzes the market for the following products: anesthesia delivery units (ADUs), anesthesia patient monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea devices and sleep diagnostic devices. The sleep therapy device market is the largest of the markets covered in this report, largely owing to the increasing awareness of sleep apnea, its risks and its co-morbidities.
There are various ways to categorize anesthesia machines or anesthesia delivery units (ADUs). The market for anesthesia delivery devices (ADUs) is segmented into three groups according to the clinical settings in which they are used. The three various settings include operating rooms in hospitals, other hospital suites and operating rooms in ambulatory surgery centers (ASCs). The segment for ADUs in hospital ORs is further divided into high- and low-complexity unit sub-segments, as defined in the introduction to this report In addition, the segment for ADUs in other hospital suites is divided into segments for units in the MRI, obstetrics and other/alternate suites, with the other/alternate category representing all hospital units that fall outside standard categories. This other/alternate category includes units that are transported between sites based on need and those that are stored for backup.
In European markets, ADUs have typically been maintained with an effective lifespan of seven to nine years, though poor economic conditions affecting many public systems have caused many hospital facilities to extend this time, often to as long as ten to twelve years for high-complexity devices. Devices manufacturers are also increasingly consolidating with larger competitors, acquiring smaller players and incorporating their technology and products into their existing product catalogue.